Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy

NCT03827278 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Talaromyces in Human Immunodeficiency Virus Negative
To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy
To Dynamically Monitor the Anti-Interferon-γ Autoantibodies

Interventions

DRUG: Voriconazole

Sponsor

Guangxi Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]